Recent Finacing
Recent Raise
NAPIGEN develops organellar genome-editing tools to deliver and edit DNA/RNA in mitochondria and chloroplasts across plants, microbes, and animals, demonstrated in yeast, algae, and plant mitochondria.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
